Cargando…
Cellular and Molecular Control of Lipid Metabolism in Idiopathic Pulmonary Fibrosis: Clinical Application of the Lysophosphatidic Acid Pathway
Idiopathic pulmonary fibrosis (IPF) is a representative disease that causes fibrosis of the lungs. Its pathogenesis is thought to be characterized by sustained injury to alveolar epithelial cells and the resultant abnormal tissue repair, but it has not been fully elucidated. IPF is currently difficu...
Autores principales: | Nakamura, Yusuke, Shimizu, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954511/ https://www.ncbi.nlm.nih.gov/pubmed/36831215 http://dx.doi.org/10.3390/cells12040548 |
Ejemplares similares
-
Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis
por: Neighbors, Margaret, et al.
Publicado: (2023) -
Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
por: Zhang, Yihang, et al.
Publicado: (2023) -
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
por: Phan, Thị Hằng Giang, et al.
Publicado: (2020) -
Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis
por: Geng, Jing, et al.
Publicado: (2022) -
The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis
por: Kim, Grace Hyun J., et al.
Publicado: (2021)